 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Achieving multi-isoform pi3k inhibition in a series of substituted 3,4-dihydro-2h-benzo[1,4]oxazines
|
|
Structure:
|
 |
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform. Chain: a. Fragment: residues 144-1102. Synonym: pi3-kinase p110 subunit gamma, ptdins-3-kinase subunit p110, pi3kgamma, pi3k, p120-pi3k. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: pik3cg. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
|
|
Resolution:
|
 |
|
2.85Å
|
R-factor:
|
0.242
|
R-free:
|
0.318
|
|
|
Authors:
|
 |
T.A.Ceska
|
|
Key ref:
|
 |
B.Perry
et al.
(2008).
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
Bioorg Med Chem Lett,
18,
4700-4704.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
08-Jul-08
|
Release date:
|
26-Aug-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P48736
(PK3CG_HUMAN) -
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1102 a.a.
846 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.7.1.153
- Phosphatidylinositol-4,5-bisphosphate 3-kinase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
1-Phosphatidyl-myo-inositol Metabolism
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
|
 |
 |
 |
 |
 |
ATP
|
+
|
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
|
=
|
ADP
|
+
|
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.2.7.11.1
- Non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + a protein = ADP + a phosphoprotein
|
 |
 |
 |
 |
 |
ATP
|
+
|
protein
|
=
|
ADP
|
+
|
phosphoprotein
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
phosphatidylinositol 3-kinase complex
|
1 term
|
 |
|
Biological process
|
phosphatidylinositol-mediated signaling
|
2 terms
|
 |
|
Biochemical function
|
binding
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
18:4700-4704
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
|
|
B.Perry,
R.Alexander,
G.Bennett,
G.Buckley,
T.Ceska,
T.Crabbe,
V.Dale,
L.Gowers,
H.Horsley,
L.James,
K.Jenkins,
K.Crépy,
C.Kulisa,
H.Lightfoot,
C.Lock,
S.Mack,
T.Morgan,
A.L.Nicolas,
W.Pitt,
V.Sabin,
S.Wright.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The SAR and pharmacokinetic profiles of a series of multi-isoform PI3K
inhibitors based on a 3,4-dihydro-2H-benzo[1,4]oxazine scaffold are disclosed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.B.Gabelli,
D.Mandelker,
O.Schmidt-Kittler,
B.Vogelstein,
and
L.M.Amzel
(2010).
Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug design.
|
| |
Biochim Biophys Acta, 1804,
533-540.
|
 |
|
|
|
|
 |
T.J.Sundstrom,
A.C.Anderson,
and
D.L.Wright
(2009).
Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity.
|
| |
Org Biomol Chem, 7,
840-850.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|